Share this
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion
December 12, 2022
Legal 500 US 2021 Highlights Cooley
July 19, 2021
Cooley Elects 19 New Partners for January 1, 2019
November 28, 2018
Jazz Pharmaceuticals Strikes Strategic Collaboration and Option Agreement with ImmunoGen
Deal diversifies + strengthens Jazz's hematology, oncology portfolio • September 12, 2017
Gevo and Butamax Successfully Resolve Multi-Year Patent Dispute
August 27, 2015
Vascular Biogenics Prices its Initial Public Offering
November 5, 2014
Cooley Advises Underwriters on T2 Biosystems IPO
August 22, 2014
Cooley Advises Adamas Pharmaceuticals on Initial Public Offering
April 30, 2014
Cooley Advises Versartis on its $145 Million IPO
March 31, 2014